Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16488408rdf:typepubmed:Citationlld:pubmed
pubmed-article:16488408lifeskim:mentionsumls-concept:C0034493lld:lifeskim
pubmed-article:16488408lifeskim:mentionsumls-concept:C2334101lld:lifeskim
pubmed-article:16488408lifeskim:mentionsumls-concept:C0037492lld:lifeskim
pubmed-article:16488408lifeskim:mentionsumls-concept:C0075193lld:lifeskim
pubmed-article:16488408lifeskim:mentionsumls-concept:C1514555lld:lifeskim
pubmed-article:16488408pubmed:issue1-3lld:pubmed
pubmed-article:16488408pubmed:dateCreated2006-3-13lld:pubmed
pubmed-article:16488408pubmed:abstractTextIn this study, the effect of staurosporine, a potent protein kinase C (PKC) inhibitor, on Na+ current (I(Na)) was examined by whole-cell patch recording in rabbit atrial myocytes. The most prominent staurosporine effect was a slowing of I(Na) inactivation and 1 microM staurosporine reduced amplitude of I(Na) about 33%. Staurosporine decreased I(Na) at all potentials and slowed the I(Na) inactivation in a dose-dependent manner, with a Kd value of 1.107+/-0.162 microM. Staurosporine did not change the recovery kinetics and show use dependence. However, the activation and the steady-state inactivation curves were shifted toward more negative potentials (-5.5 and -5.1 mV, respectively). Two other PKC inhibitors, GF 109203X (1 microM) and chelerythrine (3 microM), did not show a slowing effect on I(Na) inactivation. In conclusion, our results indicate that the slowing of I(Na) inactivation by staurosporine seems not to be through blockade of PKC rather to act directly on the Na+ channels, and the direct blocking effects of staurosporine on the Na+ channel should be taken into consideration when staurosporine is used in functional studies of ion channel modulation by protein phosphorylation.lld:pubmed
pubmed-article:16488408pubmed:languageenglld:pubmed
pubmed-article:16488408pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16488408pubmed:citationSubsetIMlld:pubmed
pubmed-article:16488408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16488408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16488408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16488408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16488408pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16488408pubmed:statusMEDLINElld:pubmed
pubmed-article:16488408pubmed:monthMarlld:pubmed
pubmed-article:16488408pubmed:issn0014-2999lld:pubmed
pubmed-article:16488408pubmed:authorpubmed-author:KimSung...lld:pubmed
pubmed-article:16488408pubmed:authorpubmed-author:EarmYung EYElld:pubmed
pubmed-article:16488408pubmed:authorpubmed-author:KoJae HongJHlld:pubmed
pubmed-article:16488408pubmed:authorpubmed-author:ParkWon SunWSlld:pubmed
pubmed-article:16488408pubmed:issnTypePrintlld:pubmed
pubmed-article:16488408pubmed:day18lld:pubmed
pubmed-article:16488408pubmed:volume534lld:pubmed
pubmed-article:16488408pubmed:ownerNLMlld:pubmed
pubmed-article:16488408pubmed:authorsCompleteYlld:pubmed
pubmed-article:16488408pubmed:pagination48-54lld:pubmed
pubmed-article:16488408pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:meshHeadingpubmed-meshheading:16488408...lld:pubmed
pubmed-article:16488408pubmed:year2006lld:pubmed
pubmed-article:16488408pubmed:articleTitleSlowing of the inactivation of voltage-dependent sodium channels by staurosporine, the protein kinase C inhibitor, in rabbit atrial myocytes.lld:pubmed
pubmed-article:16488408pubmed:affiliationDepartment of Physiology and National Research Laboratory for Cellular Signaling, Seoul National University College of Medicine, Seoul 110-799, South Korea.lld:pubmed
pubmed-article:16488408pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16488408pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:16488408pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed